Veru to report fiscal 2022 first-quarter financial results, host conference call on february 9th

Miami, jan. 26, 2022 (globe newswire) -- veru inc. (nasdaq: veru), an oncology biopharmaceutical company with a focus on developing novel medicines for the management of breast and prostate cancer, today announced that it will report financial results for its fiscal 2022 first quarter, on wednesday, february 9, 2022, before the market opens. veru's management will host a conference call that same day at 8 a.m. et to review the company's performance and to answer questions. the call will also be accessible via webcast.
VERU Ratings Summary
VERU Quant Ranking